0001415889-24-005093.txt : 20240223 0001415889-24-005093.hdr.sgml : 20240223 20240223173004 ACCESSION NUMBER: 0001415889-24-005093 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240206 FILED AS OF DATE: 20240223 DATE AS OF CHANGE: 20240223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Horn David R. CENTRAL INDEX KEY: 0001834217 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39747 FILM NUMBER: 24672781 MAIL ADDRESS: STREET 1: 3800 BRIDGE PARKWAY STREET 2: SUITE 102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seer, Inc. CENTRAL INDEX KEY: 0001726445 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 821153150 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3800 BRIDGE PARKWAY, SUITE 102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-453-0000 MAIL ADDRESS: STREET 1: 3800 BRIDGE PARKWAY, SUITE 102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: Seer Biosciences, Inc. DATE OF NAME CHANGE: 20171226 4 1 form4-02232024_100257.xml X0508 4 2024-02-06 0001726445 Seer, Inc. SEER 0001834217 Horn David R. C/O SEER, INC. 3800 BRIDGE PARKWAY, SUITE 102 REDWOOD CITY CA 94065 false true false false PRESIDENT & CFO 0 Class A Common Stock 2024-02-06 4 A 0 165038 0 A 493195 D Class A Common Stock 2024-02-22 4 S 0 12684 1.5787 D 480511 D Employee Stock Option (right to buy) 1.77 2024-02-06 4 A 0 142557 0 A 2034-02-06 Class A Common Stock 142557 142557 D Employee Stock Option (right to buy) 1.77 2024-02-06 4 A 0 140000 0 A 2034-02-06 Class A Common Stock 140000 140000 D The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on February 15, 2025. The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of RSUs. One-fourth of the shares subject to the option vest on February 6, 2025 and 1/48th of the shares vest monthly thereafter. The option is subject to vesting requirements based upon achievement of specified performance-based criteria (the "Stock Price Hurdle") which requires that the Issuer achieve a stock price equal to or greater than 200% of the option exercise price during the period beginning on the grant date and ending on February 6, 2031 (the "Performance Period"). If the Stock Price Hurdle is achieved within the Performance Period, then one-fourth of the shares subject to the option vest on the date that achievement of the Stock Price Hurdle is certified and the remaining shares vest annually thereafter in three equal installments. /s/ David Horn 2024-02-23